Virtual Screening and Biological Evaluation of Potential PD-1/PD-L1 Immune Checkpoint Inhibitors as Anti-Hepatocellular Carcinoma Agents
Open Access
- 3 September 2023
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 8 (37) , 33242-33254
Abstract
Blockade of the programmed cell death-1/programmed cell death ligand-1 (PD-1/PD-L1) immune checkpoint pathway is an efficient immunotherapeutic modality that provided significant advances in cancer treatment especially in solid tumors highly resistant to traditional therapy. Monoclonal antibodies (mAbs) and small-molecule inhibitors are the two main strategies used to block this axis with mAbs suffering from many limitations. Accordingly, the current alternative is the development of small-molecule PD-1/PD-L1 inhibitors. Here, we present a sequential virtual screening (VS) protocol involving pharmacophore screening followed by molecular docking for the discovery of novel PD-L1 inhibitors. The VS protocol resulted in the discovery of eight novel compounds. A 100 ns MD simulation showed two compounds, H4 and H6, exhibiting a stable binding mode at the PD-L1 dimer interface. Upon evaluation of their immunological activities, the two compounds induced higher cytokines levels (IL-2, IL-6, and INF-γ) relative to BMS-202, 72 h post treatment of PBMCs of HCC patients. Thus, the discovered hits represent potential leads for the development of novel classes targeting the PD-L1 receptor as anti-hepatocellular carcinoma agents.Keywords
Funding Information
- Egyptian Academy of Scientific Research and Technology (90D/2021)
This publication has 37 references indexed in Scilit:
- Directory of Useful Decoys, Enhanced (DUD-E): Better Ligands and Decoys for Better BenchmarkingJournal of Medicinal Chemistry, 2012
- The role of the PD‐1 pathway in autoimmunity and peripheral toleranceAnnals of the New York Academy of Sciences, 2011
- The PD‐1 pathway in tolerance and autoimmunityImmunological Reviews, 2010
- Molecular dynamics simulation studies and in vitro site directed mutagenesis of avian beta-defensin Apl_AvBD2BMC Bioinformatics, 2010
- Crystal structure of the complex between programmed death-1 (PD-1) and its ligand PD-L2Proceedings of the National Academy of Sciences, 2008
- The PD-1/PD-L1 complex resembles the antigen-binding Fv domains of antibodies and T cell receptorsProceedings of the National Academy of Sciences, 2008
- The Amber biomolecular simulation programsJournal of Computational Chemistry, 2005
- Development and validation of a genetic algorithm for flexible docking 1 1Edited by F. E. CohenJournal of Molecular Biology, 1997
- VMD: Visual molecular dynamicsJournal of Molecular Graphics, 1996
- Langevin dynamics of peptides: The frictional dependence of isomerization rates of N‐acetylalanyl‐N′‐methylamideBiopolymers, 1992